How does the risk of cardiovascular death and cardiovascular risk factor profiles differ between socioeconomic classes in Poland: A country in transition
Paweł Nadrowski(Medical University of Silesia), Krystyna Kozakiewicz(Medical University of Silesia), Arkadiusz Niklas(Poznan University of Medical Sciences), Wojciech Wojakowski(Cedars-Sinai Medical Center), Magdalena Kwaśniewska(Medical University of Lodz), Ewa Podolecka(Medical University of Silesia), Andrzej Pająk(Jagiellonian University), Tomasz Zdrojewski(Gdańsk Medical University), Michał Skrzypek(Medical University of Silesia), Agnieszka Doryńska(Institute of Cardiology), Andrzej Tykarski(Poznan University of Medical Sciences), Wojciech Drygas(Medical University of Lodz), Wojciech Bielecki(Medical University of Lodz)
Cited by 9
Related Papers
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k